RAC1 and inflammatory bowel disease: They found that functional genetic polymorphisms of RAC1, which were located in the regions involved in an mRNA splicing process and modified the amino acid sequence of Rac1, affected its expression and modulated the risk of adverse drug reaction in patients with IBD under thiopurine treatment.